Magnesium sulphate and amiodarone prophylaxis for prevention of postoperative arrhythmia in coronary by-pass operations

نویسندگان

  • Osman Tiryakioglu
  • Sinan Demirtas
  • Hasan Ari
  • Selma Kenar Tiryakioglu
  • Kagan Huysal
  • Ozer Selimoglu
  • Ahmet Ozyazicioglu
چکیده

BACKGROUND The aim of this study was to investigate the use of prophylactic magnesium sulphate and amiodarone in treating arrhythmias that may occur following coronary bypass grafting operations. METHODS The study population consisted of 192 consecutive patients who were undergoing coronary artery bypass grafting (CABG). Sixty-four patients were given 3 g of magnesium sulphate (MgSO4) [20 ml = 24.32 mEq/L Mg(+2)] in 100 cc of isotonic 0.9% solution over 2 hours intravenously at the following times: 12 hours prior to the operation, immediately following the operation, and on postoperative days 1, 2, and 3 (Group 1). Another group of 64 patients was given a preoperative infusion of amiodarone (1200 mg) on first post-operative day (Group 2). After the operation amiodarone was administered orally at a dose of 600 mg/day. Sixty-four patients in group 3 (control group) had 100 cc. isotonic 0.9% as placebo, during the same time periods. RESULTS In the postoperative period, the magnesium values were significantly higher in Group 1 than in Group 2 for all measurements. The use of amiodarone for total arrhythmia was significantly more effective than prophylactic treatment with magnesium sulphate (p = 0.015). There was no difference between the two drugs in preventing supraventricular arrhythmia, although amiodarone significantly delayed the revealing time of atrial fibrillation (p = 0.026). Ventricular arrhythmia, in the form of ventricular extra systole, was more common in the magnesium prophylaxis group. The two groups showed no significant differences in other operative or postoperative measurements. No side effects of the drugs were observed. CONCLUSION Prophylactic use of magnesium sulphate and amiodarone are both effective at preventing arrhythmia that may occur following coronary by-pass operations. Magnesium sulphate should be used in prophylactic treatment since it may decrease arrhythmia at low doses. If arrhythmia should occur despite this treatment, intervention with amiodarone may be preferable.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia.

OBJECTIVE To assess if prophylaxis with moderate doses of amiodarone in the postoperative period of cardiac surgery (coronary artery bypass grafting and/or valve surgery), reduces the incidence of atrial fibrillation in patients with high risk for developing this arrhythmia. METHODS A randomized and prospective clinical study involving 68 patients who underwent elective cardiac surgery. Mean ...

متن کامل

Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review

Atrial Fibrillation (AF) is the most common arrhythmia occurring after cardiac surgery. Its incidence varies depending on type of surgery. Postoperative AF may cause hemodynamic deterioration, predispose to stroke and increase mortality. Effective treatment for prophylaxis of postoperative AF is vital as reduces hospitalization and overall morbidity. Beta-blockers, have been proved to prevent e...

متن کامل

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

OBJECTIVES To assess the clinical and cost-effectiveness of magnesium sulphate compared with sotalol, and to assess the clinical effectiveness of magnesium sulphate compared with placebo in the prevention of atrial fibrillation (AF) in patients who have had a coronary artery bypass graft (CABG). DATA SOURCES Major electronic databases were searched from December 2003 to May 2007. REVIEW MET...

متن کامل

بررسی تأثیر سولفات منیزیم در بهبود پیش آگهی بیمارستانی بیماران مبتلا به انفارکتوس حاد میوکارد توأم با ST elevation

Acute myocardial infarction (AMI) is usually due to thrombotic occlusion of coronary arteries.Interacellular magnesium decreases after AMI. One of the drugs in treatment of AMI is parenteral magnesium sulphate that its efficacy is still ambiguous in decreasing ventricular arrhythmia and in-hospital mortality rate.We decided to investigate magnesium efficacy in in-hospit...

متن کامل

Intravenous Magnesium Sulphate and Its Combination with Oral Vitamin C for AF Prophylaxis in Patients Undergoing Coronary Artery Bypass Surgery: A Randomized Double Blind Controlled Trial

Atrial fibrillation (AF) is one of the most commonly encountered complications following coronary artery bypass grafting, whose treatment modalities are still not definite. In this prospective randomized double blind controlled trial we evaluated the adjuvant role of oral vitamin C with intravenous magnesium sulphate for the prevention of postoperative AF among the patients who underwent CABG u...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of Cardiothoracic Surgery

دوره 4  شماره 

صفحات  -

تاریخ انتشار 2009